AP2895A - Nanodispersion - Google Patents

Nanodispersion

Info

Publication number
AP2895A
AP2895A AP2010005314A AP2010005314A AP2895A AP 2895 A AP2895 A AP 2895A AP 2010005314 A AP2010005314 A AP 2010005314A AP 2010005314 A AP2010005314 A AP 2010005314A AP 2895 A AP2895 A AP 2895A
Authority
AP
ARIPO
Prior art keywords
nanodispersion
Prior art date
Application number
AP2010005314A
Other languages
English (en)
Other versions
AP2010005314A0 (en
Inventor
Ajay Jaysingh Khopade
Subhas Balaram Bhowmick
N Arulsudar
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40853553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2895(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of AP2010005314A0 publication Critical patent/AP2010005314A0/en
Application granted granted Critical
Publication of AP2895A publication Critical patent/AP2895A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AP2010005314A 2007-12-24 2008-12-23 Nanodispersion AP2895A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2527MU2007 2007-12-24
PCT/IN2008/000857 WO2009087678A2 (fr) 2007-12-24 2008-12-23 Nanodispersion

Publications (2)

Publication Number Publication Date
AP2010005314A0 AP2010005314A0 (en) 2010-08-31
AP2895A true AP2895A (en) 2014-05-31

Family

ID=40853553

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005314A AP2895A (en) 2007-12-24 2008-12-23 Nanodispersion

Country Status (20)

Country Link
US (2) US8586062B2 (fr)
EP (2) EP2853264A1 (fr)
JP (2) JP5656643B2 (fr)
KR (1) KR101505419B1 (fr)
CN (1) CN101909614B (fr)
AP (1) AP2895A (fr)
AU (1) AU2008346121B2 (fr)
BR (1) BRPI0821514B8 (fr)
CA (1) CA2710525C (fr)
CO (1) CO6290681A2 (fr)
DK (1) DK2231144T3 (fr)
EA (1) EA016434B1 (fr)
ES (1) ES2509490T3 (fr)
IL (1) IL206584A0 (fr)
MX (1) MX2010007076A (fr)
NZ (1) NZ586343A (fr)
PL (1) PL2231144T3 (fr)
UA (1) UA100543C2 (fr)
WO (1) WO2009087678A2 (fr)
ZA (1) ZA201004450B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010146606A1 (fr) * 2009-06-19 2010-12-23 Sun Pharma Advanced Research Company Ltd., Nanodispersion d'un médicament et son procédé de préparation
CN102038635A (zh) * 2009-10-23 2011-05-04 天津天士力集团有限公司 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
KR20110056042A (ko) * 2009-11-20 2011-05-26 주식회사유한양행 종양세포 표적지향을 위한 나노 입자 및 이의 제조방법
BR112012028037A2 (pt) 2010-05-03 2016-08-02 Teikoku Pharma Usa Inc formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
CN102078300B (zh) * 2011-01-27 2012-01-11 海南美大制药有限公司 托拉塞米脂质体固体制剂
CN102366409B (zh) * 2011-09-14 2013-03-20 海南灵康制药有限公司 一种尼扎替丁脂质体固体制剂
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014153042A1 (fr) 2013-03-14 2014-09-25 Griffith Laboratories International, Inc. Composition fongicide naturelle
WO2015184238A1 (fr) * 2014-05-30 2015-12-03 Oms Investments, Inc. Compositions de dispersion nanométrique à base d'eau et procédés de production correspondants
KR101692314B1 (ko) * 2015-03-27 2017-01-03 주식회사 주빅 지용성 약물의 생분해성 고분자 내 용해 시스템: 스마트 폴리머 시스템
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
JP2018516964A (ja) * 2015-06-09 2018-06-28 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 局所進行性または転移性である肝内もしくは肝外胆管または胆嚢のカルシノーマに罹患する患者を治療する方法
CN107551390A (zh) * 2017-08-21 2018-01-09 常熟佳禾生物科技有限公司 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法
EP3768274B1 (fr) * 2018-03-19 2023-11-15 Epicyt Pharma AB Composition comprenant une combinaison d'acide glycocholique et d'acide butyrique ou d'acide oléique pour le traitement de l'ostéoporose
US11423574B2 (en) 2019-12-17 2022-08-23 Emma Ruccio Method and apparatus for detecting scoliosis
US11877717B2 (en) 2019-12-17 2024-01-23 Emma Ruccio Method and apparatus for detecting scoliosis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021174A1 (fr) * 1999-09-23 2001-03-29 Dabur Research Foundation Formulations de paclitaxel contenus dans des nanoparticules de micelles polymeriques
WO2003077882A2 (fr) * 2002-03-18 2003-09-25 Labopharm Inc. Preparation de nanodispersions stabilisees steriles
WO2004039351A2 (fr) * 2002-10-31 2004-05-13 Maria Rosa Gasco Compositions pharmaceutiques adaptees au traitement de maladies ophtalmiques
US20060188566A1 (en) * 2005-02-24 2006-08-24 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
WO2007069272A2 (fr) * 2005-10-21 2007-06-21 Panacea Biotec Limited Nouvelles compositions ameliorees pour la therapie du cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018A (en) * 1849-01-09 Improvement in bog-cutters
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR19990075621A (ko) 1998-03-23 1999-10-15 임성주 경사 평판형 배양조
US6017948A (en) 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6365191B1 (en) 1999-02-17 2002-04-02 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
TWI230616B (en) 2000-09-25 2005-04-11 Ind Tech Res Inst Liposome for incorporating large amounts of hydrophobic substances
EP1387676A2 (fr) * 2001-05-01 2004-02-11 Angiotech Pharmaceuticals, Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
DE10124952A1 (de) * 2001-05-21 2002-12-12 Bayer Ag Verfahren zur Herstellung von Nanodispersionen
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20050288521A1 (en) * 2004-06-29 2005-12-29 Phytogen Life Sciences Inc. Semi-synthetic conversion of paclitaxel to docetaxel
US20090118354A1 (en) 2005-06-17 2009-05-07 Mayne Pharma Limited Liquid Pharmaceutical Formulations of Docetaxel
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021174A1 (fr) * 1999-09-23 2001-03-29 Dabur Research Foundation Formulations de paclitaxel contenus dans des nanoparticules de micelles polymeriques
WO2003077882A2 (fr) * 2002-03-18 2003-09-25 Labopharm Inc. Preparation de nanodispersions stabilisees steriles
WO2004039351A2 (fr) * 2002-10-31 2004-05-13 Maria Rosa Gasco Compositions pharmaceutiques adaptees au traitement de maladies ophtalmiques
US20060188566A1 (en) * 2005-02-24 2006-08-24 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
WO2007069272A2 (fr) * 2005-10-21 2007-06-21 Panacea Biotec Limited Nouvelles compositions ameliorees pour la therapie du cancer

Also Published As

Publication number Publication date
WO2009087678A3 (fr) 2009-09-11
EP2231144A2 (fr) 2010-09-29
EP2231144B1 (fr) 2014-07-02
CA2710525A1 (fr) 2009-07-16
JP2015110565A (ja) 2015-06-18
EP2231144A4 (fr) 2011-01-12
EA016434B1 (ru) 2012-04-30
CA2710525C (fr) 2017-08-22
ES2509490T3 (es) 2014-10-17
US8586062B2 (en) 2013-11-19
AP2010005314A0 (en) 2010-08-31
MX2010007076A (es) 2010-09-30
US20140030352A1 (en) 2014-01-30
UA100543C2 (ru) 2013-01-10
EP2853264A1 (fr) 2015-04-01
US20100297244A1 (en) 2010-11-25
JP5937180B2 (ja) 2016-06-22
KR101505419B1 (ko) 2015-03-30
CN101909614A (zh) 2010-12-08
CN101909614B (zh) 2015-04-15
JP5656643B2 (ja) 2015-01-21
ZA201004450B (en) 2011-03-30
AU2008346121A1 (en) 2009-07-16
DK2231144T3 (da) 2014-10-13
BRPI0821514B8 (pt) 2021-05-25
BRPI0821514B1 (pt) 2020-03-10
NZ586343A (en) 2012-03-30
WO2009087678A2 (fr) 2009-07-16
AU2008346121B2 (en) 2013-10-10
KR20100112564A (ko) 2010-10-19
PL2231144T3 (pl) 2014-12-31
CO6290681A2 (es) 2011-06-20
BRPI0821514A2 (pt) 2016-09-27
JP2011507946A (ja) 2011-03-10
IL206584A0 (en) 2010-12-30
EA201070793A1 (ru) 2010-12-30

Similar Documents

Publication Publication Date Title
AP2895A (en) Nanodispersion
EP2212908A4 (fr) Transistor à effet de champ à jonction à ailette
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (fr) Spiroindalones
EP2211752A4 (fr) Biopulpe
GB0723387D0 (en) Improved dehumldifier
GB0718749D0 (en) Deadleg
EP2134587A4 (fr) Agencement de barre intermédiaire de traction
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0700595D0 (en) Holecutter
GB0818126D0 (en) Nanodispersion
AU3606P (en) Jaywick xTriticosecale
AU3642P (en) TAS100 Dianella tasmanica
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3646P (en) TAS300 Dianella tasmanica
AU3702P (en) DarwinGold Dianella ensifolia
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3595P (en) Goldust Strobilanthes anisophyllus
GB0720347D0 (en) Fitted headscarf
GB0714068D0 (en) No riveal
GB0713975D0 (en) No Riveal
GB0721702D0 (en) Hydrogienic globaltechnology limited
AU316590S (en) Multi-sander
GB0700085D0 (en) Multi-cleanser
GB0700193D0 (en) Plug-guard